Showing 961-970 of 5957 results for "".
First Myopia Drug Approved in Europe
https://modernod.com/podcasts/eyewire-news-the-podcast/first-myopia-drug-approved-in-europe/37088/The first pharmaceutical treatment for myopia is approved in Europe; the FDA sets a target action date for a first-of-its-kind presbyopia drop; and John Berdahl, MD, discusses the reimbursement landscape in ophthalmology. Learn more about your ad choices. Visit megaphone.fm/adchoicesOculomics • IPL & Ocular Rosacea
https://modernod.com/podcasts/the-mod-pod/oculomics-ipl-ocular-rosacea/36881/Join Cecelia Koetting, OD, FAAO, Dipl ABO, on this month's episode of The MOD Pod as she learns about how imaging and biomarkers can be used to diagnose, manage, and treat ocular and systemic conditions (aka oculomics) from Modern Optometry contributor Shane Kannarr, OD. Dr. Koetting's second guestAn Updated Overview of Inflammatory Dry Eye
https://modernod.com/topics/ocular-surface/an-updated-overview-of-inflammatory-dry-eye/38860/Essential knowledge for the diagnosis and management of this complex condition.Know Your Vitreomacular Interface Disorders
https://modernod.com/topics/retina/know-your-vitreomacular-interface-disorders/38714/Many of these conditions have similarities and associated sight-threatening sequelae; it’s vital that we can correctly recognize and manage them.Entry Points Into Ocular Aesthetics
https://modernod.com/topics/business/entry-points-into-ocular-aesthetics/38622/Adding aesthetics to your practice can attract new patients and revenue, but it’s best to start small and build out.Expanding the Scope of Practice
https://modernod.com/mod-issues/2026-mar-apr/expanding-the-scope-of-practice/56862/This is an imperative step to meet US patients’ eye care needs.The Advent of Standalone MIGS and Opportunities for Patient Engagement
https://modernod.com/mod-issues/supplements-inserts/the-advent-of-standalone-migs-and-opportunities-for-patient-engagement/38543/Insights on patient identification, pearls for success, and perspective on the role of optometry in connecting patients with options for glaucoma management.Visionary Breakthroughs: A Spotlight on Innovations in Eye Care (Part 2 of 2)
https://modernod.com/podcasts/eyewire-news-the-podcast/visionary-breakthroughs-a-spotlight-on-innovations-in-eye-care-part-2-of-2/39873/Industry executives discuss future innovations and breakthroughs that are poised to reshape the future of ophthalmic care. Learn more about your ad choices. Visit megaphone.fm/adchoicesEMPOWER - Patient Communication: Building Trust and a Continuity of Care
https://modernod.com/podcasts/the-mod-pod/empower-patient-communication-building-trust-and-a-continuity-of-care/39856/In this third EMPOWER podcast, Paul Hammond, OD, FAAO, and Jessica O. Yu, OD, FAAO, FSLS, dive into the art of patient communication with Jacob Lang, OD, FAAO. From treatment options and managing costs to fostering relationships across decades of care, they outline how clarity and compassion can traGlaukos' MIGS Technology Certified in Europe; New Phase 3 Data for Presbyopia Drop
https://modernod.com/podcasts/eyewire-news-the-podcast/glaukos-migs-technology-certified-in-europe-new-phase-3-data-for-presbyopia-drop/37091/Glaukos receives European Union certification for several of its MIGS technologies; Opus Genetics and Viatris present phase 3 results for their investigational presbyopia eye drop; and J&J launches the first and only daily disposable contact lens for people with both astigmatism and presbyopia.